http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2015002472-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2015-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c33310153ecd0dba915ed0c10d353aa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fab235a66214dc8987ff7317cd7e5085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b1294d8e111c588d85d051222393df6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9227d6e47bd299122d9fb46611a0d851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a531b3909478b0b78b4b892e29eb6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5472342f763850cbc2c00c3a8c92ef6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db2abad866e5bbd14294328135ae4fb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7777ee840c0cdde82ab8e7aa32c78a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fce7c6822b771c591c481693c9db156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9cca8e7ae5d1ebcb515aad9b4a92bdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bf2933487ce5b7b1dc9e429153876b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_710010e06159505706cbcadd051f5d5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bfd7d3a6d1a35932cbb2625c7168add
publicationDate 2016-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2015002472-A1
titleOfInvention As inhibitors of mutant idh-yl-oxazolidin-2-ones 3-pyrimidin-4.
abstract Compounds derived from 3-pyrimidin-4-yl-oxazolidin-2-one; pharmaceutical composition comprising and use in the treatment or disorder associated with a mutant HDI protein that has a neomorphic activity, such as cancer
priorityDate 2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422155356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117865357

Total number of triples: 37.